N/A
Completed N=94
Innovation Labs to Enhance Collaboration
Collaboration Attitudes and Behavior
Source: ClinicalTrials.gov NCT05395286 ↗
Enrolled (actual)
94
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcomePrimary: MATRICx Collaboration Benefits/Motivators Scale — 3.41; 3.48; 3.29; 3.31 Score on a scale
Summary
Conduct and evaluate the impact of two week-long Innovation Labs on collaboration attitudes and behavior among early career scholars. Applicants to each Innovation Lab will be screened and then randomized to either the Innovation Lab group or a control group.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY MATRICx Collaboration Benefits/Motivators Scale |
3.41; 3.48; 3.29; 3.31; 3.31; 3.25 | — |
| PRIMARY MATRICx Collaboration Barriers/Threats Scale |
1.47; 1.45; 1.60; 1.60; 1.60; 1.65 | — |
| PRIMARY Transdisciplinary Orientation Scale |
4.4; 4.4; 4.2; 4.1; 4.3; 4.4 | — |
| PRIMARY Collaboration Network Size |
27.6; 26.7; 34.6; 30.1 | — |
| SECONDARY Self-Reported Number of Grants Submitted Per Year |
2.7; 2.8; 2.6; 1.6 | — |
| SECONDARY ILab Met Goal - New Collab |
4.3; 3.7; 2.9 | — |
| SECONDARY ILab Met Goal - Novel Proposals |
3.7; 3.4; 2.6 | — |
| SECONDARY ILab - Recommend |
4.4; 4.3; 3.8 | — |
| SECONDARY ILab - Positive Impact |
4.4; 4.1; 3.7 | — |
Eligibility Criteria
Inclusion Criteria
- Completion of application and baseline assessment.
- Faculty at a NIH CTSA hub institution or regional partner.
- Early stage investigators (NIH-defined as "within 10 years of completing his/her terminal research degree or is within 10 years of completing medical residency (or the equivalent)") who are emerging as independent scholars.
- Ratings of goodness of fit with the topic of the Innovation Lab. Applications were reviewed for the above criteria and ranked by committee according to goodness of fit with the topic of the Innovation Lab, the quality and quantity of academic productivity and collaboration, and contribution to diversity of perspectives among Lab participants (e.g., biomedical and social/psychological, basic and applied). Top-ranked applicants were retained for randomization to the Innovation Lab group or control group.
Data sourced from ClinicalTrials.gov (NCT05395286). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.